ArticlePharmaceutics2026

Dendritic Mesoporous Silica-Modified Decellularized Bone Matrix Scaffold for Sustained Teriparatide Delivery in Bone Defect Repair: Characterization, Drug Release, and In Vitro Biological Performance.

Lin Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.